STAAR Surgical Relocates HQ to Lake Forest, CA

Ticker: STAA · Form: 8-K · Filed: Jan 8, 2024 · CIK: 718937

Staar Surgical Co 8-K Filing Summary
FieldDetail
CompanyStaar Surgical Co (STAA)
Form Type8-K
Filed DateJan 8, 2024
Risk Levellow
Pages2
Reading Time3 min
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: corporate-governance, administrative-change

TL;DR

**STAAR Surgical moved its main office, no big deal for the stock.**

AI Summary

STAAR Surgical Co. filed an 8-K on January 8, 2024, to update its corporate address from 1911 Walker Ave, Monrovia, CA 91016 to 25651 Atlantic Ocean Drive, Lake Forest, California 92630. This administrative change, reported under Items 2.02 and 9.01, indicates a physical relocation of their principal executive offices. For investors, this primarily signals a logistical update rather than a change in financial performance or strategic direction, meaning it's unlikely to directly impact the stock's value.

Why It Matters

This filing primarily indicates an administrative change in STAAR Surgical's physical location, which typically has no direct impact on the company's financial health or stock performance.

Risk Assessment

Risk Level: low — The filing reports a change of address, which is a routine administrative update and does not present significant financial or operational risk.

Analyst Insight

Investors should note this administrative update but recognize it has no direct bearing on the company's financial performance or strategic outlook, so no immediate investment action is warranted based solely on this filing.

Key Players & Entities

  • STAAR Surgical Co. (company) — the registrant filing the 8-K
  • 1911 Walker Ave, Monrovia, CA 91016 (address) — STAAR Surgical's former business address
  • 25651 Atlantic Ocean Drive, Lake Forest, California 92630 (address) — STAAR Surgical's new principal executive offices address
  • January 8, 2024 (date) — date of earliest event reported and filing date

FAQ

What was the previous principal executive office address for STAAR Surgical Co.?

According to the filing, STAAR Surgical Co.'s former business address was 1911 Walker Ave, Monrovia, CA 91016.

What is the new principal executive office address for STAAR Surgical Co.?

The new principal executive office address for STAAR Surgical Co. is 25651 Atlantic Ocean Drive, Lake Forest, California 92630.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on January 8, 2024.

Under which items of Form 8-K was this information filed?

This 8-K filing includes information under 'Results of Operations and Financial Condition', 'Regulation FD Disclosure', and 'Financial Statements and Exhibits', though the primary content is an address change.

What is STAAR Surgical Co.'s trading symbol and on which exchange is it registered?

STAAR Surgical Co.'s trading symbol is STAA, and it is registered on NASDAQ.

Filing Stats: 644 words · 3 min read · ~2 pages · Grade level 11.3 · Accepted 2024-01-08 09:00:21

Filing Documents

02 Results of Operations and Financial Condition

Item 2.02 Results of Operations and Financial Condition. On January 8, 2024, STAAR Surgical Company (the “Company”) published a press release reporting selected preliminary financial results for the quarter and fiscal year ended December 29, 2023, a copy of which is furnished as Exhibit 99.1 to this Report and is incorporated herein by this reference. The financial information is unaudited and subject to adjustment in the final audited financial statements to be filed with the Company’s Annual Report on Form 10-K. The Company expects to report its complete 2023 financial results on its fourth-quarter and full-year earnings call, which it will hold later in the first quarter of 2024.

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. Representatives of the Company will give presentations to investors commencing on January 8, 2024. A copy of the slide presentation they will share is furnished as Exhibit 99.2 to this Report and is incorporated herein by this reference. The information furnished herewith pursuant to Items 2.02 and 7.01 of this Current Report, including Exhibits 99.1 and 99.2 shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information in Items 2.02 and 7.01 of this Current Report shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report, regardless of any general incorporation language in the filing .

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits Exhibit No. Description 99.1 Press release of the Company dated January 8, 2024. 99.2 104 Slide presentation of the Company dated January 8, 2024 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. STAAR Surgical Company January 8, 2024 By: /s/ Tom Frinzi Thomas Frinzi President and Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.